Skip to main content

Table 3 Univariate analysis of all patients

From: Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer

Factors

Number of patients

1-year LRPFS (%)

p-value

1-year OS (%)

p-value

Age (years)

     

 < 66

58

52.6

0.039

64.7

0.11

 ≥66

49

81.0

 

85.5

 

Gender

     

 Male

45

71.9

0.88

77.4

0.67

 Female

62

59.5

 

72.0

 

Tumor size

     

 < 3 cm

64

65.0

0.11

77.7

0.047

 ≥3 cm

43

66.7

 

69.3

 

Radiation modality

     

 3DCRT

80

63.2

0.035

68.2

0.037

 IMRT

27

73.1

 

92.3

 

PS

     

 0

52

65.2

0.55

78.3

0.053

 1–2

55

66.2

 

70.5

 

Pretreatment CA19–9 (U/ml)

     

 < 300

64

76.7

0.0026

82.2

0.010

 ≥300

43

50.0

 

62.8

 

Tumor location

     

 Body/Tail

50

69.4

0.24

76.0

0.21

 Head/Neck

57

62.3

 

72.8

 
  1. Abbreviations; LRPFS locoregional progression free survival, OS overall survival